日本所有疾病的综合成本:超老龄化社会疾病社会负担的测量

IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES Health Policy and Technology Pub Date : 2023-09-01 DOI:10.1016/j.hlpt.2023.100774
Kunichika Matsumoto, Kanako Seto, Yosuke Hatakeyama, Ryo Onishi, Koki Hirata, Tomonori Hasegawa
{"title":"日本所有疾病的综合成本:超老龄化社会疾病社会负担的测量","authors":"Kunichika Matsumoto,&nbsp;Kanako Seto,&nbsp;Yosuke Hatakeyama,&nbsp;Ryo Onishi,&nbsp;Koki Hirata,&nbsp;Tomonori Hasegawa","doi":"10.1016/j.hlpt.2023.100774","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Evaluation of the social burden of illness is important for policy decision-making. However, policy-makers find indicators traditionally used in the healthcare field difficult to use because calculation of these indicators is complex and the unit of indicators is often expressed on “years” basis. The aim of this study was to measure the burden of all diseases using the Comprehensive Cost of Illness (C<img>COI) method and to provide indicators that are easy to use for policy-making.</p></div><div><h3>Methods</h3><p>Utilizing government-based nationwide statistical data, we used the C<img>COI method to estimate the social burden of illness from 2002 to 2017. C<img>COI consists of direct costs (medical direct cost and formal care cost) and indirect costs (morbidity cost, mortality cost, and informal care cost).</p></div><div><h3>Results</h3><p>From 2002 to 2017, C<img>COI increased from 66.5 trillion yen (12.9% of the gross domestic product [GDP]) to 90.6 trillion yen (16.6% of GDP). From 2002 to 2017, the three top-ranked diseases influencing C<img>COI did not change. The ranking of these diseases (from first to third) is as follows: circulatory system diseases, neoplasms, and digestive diseases.</p></div><div><h3>Conclusions</h3><p>The trend of C<img>COI is consistent with the trends of national health expenditure and disability-adjusted life years. The C<img>COI method is expressed in monetary terms, so the effects of aging and the development of medical technology are represented by trends in each cost and are considered valuable as the basis of health policy, instead of national health expenditure.</p></div><div><h3>Public Interest Summary</h3><p>Measuring the social burden of disease is important for making policy decisions. There have been indicators to measure the burden of disease in the past, but they have been complex and difficult to use because they are measured in \"years\". We have developed a comprehensive cost-of-illness method (C<img>COI) that includes the burden of long-term care by applying a method called the cost-of-illness method (COI), which expresses the burden of illness in monetary terms. Using this method, we measured the cost of illness in Japan's aging population, which in 2017 was 66.5 trillion yen (approximately US$532 billion), accounting for 12.9% of GDP. Since this method expresses the burden in monetary terms, it is expected to be a useful indicator for policy making.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comprehensive cost of illness of all diseases in Japan: Measurement of the social burden of diseases in a super-aged society\",\"authors\":\"Kunichika Matsumoto,&nbsp;Kanako Seto,&nbsp;Yosuke Hatakeyama,&nbsp;Ryo Onishi,&nbsp;Koki Hirata,&nbsp;Tomonori Hasegawa\",\"doi\":\"10.1016/j.hlpt.2023.100774\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Evaluation of the social burden of illness is important for policy decision-making. However, policy-makers find indicators traditionally used in the healthcare field difficult to use because calculation of these indicators is complex and the unit of indicators is often expressed on “years” basis. The aim of this study was to measure the burden of all diseases using the Comprehensive Cost of Illness (C<img>COI) method and to provide indicators that are easy to use for policy-making.</p></div><div><h3>Methods</h3><p>Utilizing government-based nationwide statistical data, we used the C<img>COI method to estimate the social burden of illness from 2002 to 2017. C<img>COI consists of direct costs (medical direct cost and formal care cost) and indirect costs (morbidity cost, mortality cost, and informal care cost).</p></div><div><h3>Results</h3><p>From 2002 to 2017, C<img>COI increased from 66.5 trillion yen (12.9% of the gross domestic product [GDP]) to 90.6 trillion yen (16.6% of GDP). From 2002 to 2017, the three top-ranked diseases influencing C<img>COI did not change. The ranking of these diseases (from first to third) is as follows: circulatory system diseases, neoplasms, and digestive diseases.</p></div><div><h3>Conclusions</h3><p>The trend of C<img>COI is consistent with the trends of national health expenditure and disability-adjusted life years. The C<img>COI method is expressed in monetary terms, so the effects of aging and the development of medical technology are represented by trends in each cost and are considered valuable as the basis of health policy, instead of national health expenditure.</p></div><div><h3>Public Interest Summary</h3><p>Measuring the social burden of disease is important for making policy decisions. There have been indicators to measure the burden of disease in the past, but they have been complex and difficult to use because they are measured in \\\"years\\\". We have developed a comprehensive cost-of-illness method (C<img>COI) that includes the burden of long-term care by applying a method called the cost-of-illness method (COI), which expresses the burden of illness in monetary terms. Using this method, we measured the cost of illness in Japan's aging population, which in 2017 was 66.5 trillion yen (approximately US$532 billion), accounting for 12.9% of GDP. Since this method expresses the burden in monetary terms, it is expected to be a useful indicator for policy making.</p></div>\",\"PeriodicalId\":48672,\"journal\":{\"name\":\"Health Policy and Technology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Health Policy and Technology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2211883723000503\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEALTH POLICY & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Policy and Technology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211883723000503","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

背景疾病社会负担评估对政策决策具有重要意义。然而,决策者发现传统上用于医疗保健领域的指标很难使用,因为这些指标的计算很复杂,而且指标的单位通常以“年”为单位。本研究的目的是使用疾病综合成本(CCOI)方法来衡量所有疾病的负担,并提供易于用于决策的指标。方法利用全国政府统计数据,采用CCOI方法估算2002-2017年的社会疾病负担。CCOI包括直接成本(医疗直接成本和正式护理成本)和间接成本(发病率成本、死亡率成本和非正式护理成本)。结果从2002年到2017年,CCOI从66.5万亿日元(占国内生产总值的12.9%)增加到90.6万亿日元(GDP的16.6%)。从2002年到2017年,影响CCOI的三种顶级疾病没有变化。这些疾病的排名(从第一到第三)如下:循环系统疾病、肿瘤和消化系统疾病。结论CCOI的趋势与全国卫生支出和残疾调整寿命的趋势一致。CCOI方法以货币形式表示,因此老龄化和医疗技术发展的影响以每种成本的趋势来表示,并被认为是有价值的卫生政策基础,而不是国家卫生支出。公共利益总结衡量疾病的社会负担对决策很重要。过去曾有衡量疾病负担的指标,但它们一直很复杂,很难使用,因为它们是以“年”为单位衡量的。我们开发了一种综合疾病成本法(CCOI),通过应用一种称为疾病成本法的方法来包括长期护理的负担,该方法以货币形式表示疾病负担。使用这种方法,我们测量了日本老龄化人口的疾病成本,2017年为66.5万亿日元(约5320亿美元),占GDP的12.9%。由于这种方法用货币来表示负担,因此有望成为制定政策的有用指标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Comprehensive cost of illness of all diseases in Japan: Measurement of the social burden of diseases in a super-aged society

Background

Evaluation of the social burden of illness is important for policy decision-making. However, policy-makers find indicators traditionally used in the healthcare field difficult to use because calculation of these indicators is complex and the unit of indicators is often expressed on “years” basis. The aim of this study was to measure the burden of all diseases using the Comprehensive Cost of Illness (CCOI) method and to provide indicators that are easy to use for policy-making.

Methods

Utilizing government-based nationwide statistical data, we used the CCOI method to estimate the social burden of illness from 2002 to 2017. CCOI consists of direct costs (medical direct cost and formal care cost) and indirect costs (morbidity cost, mortality cost, and informal care cost).

Results

From 2002 to 2017, CCOI increased from 66.5 trillion yen (12.9% of the gross domestic product [GDP]) to 90.6 trillion yen (16.6% of GDP). From 2002 to 2017, the three top-ranked diseases influencing CCOI did not change. The ranking of these diseases (from first to third) is as follows: circulatory system diseases, neoplasms, and digestive diseases.

Conclusions

The trend of CCOI is consistent with the trends of national health expenditure and disability-adjusted life years. The CCOI method is expressed in monetary terms, so the effects of aging and the development of medical technology are represented by trends in each cost and are considered valuable as the basis of health policy, instead of national health expenditure.

Public Interest Summary

Measuring the social burden of disease is important for making policy decisions. There have been indicators to measure the burden of disease in the past, but they have been complex and difficult to use because they are measured in "years". We have developed a comprehensive cost-of-illness method (CCOI) that includes the burden of long-term care by applying a method called the cost-of-illness method (COI), which expresses the burden of illness in monetary terms. Using this method, we measured the cost of illness in Japan's aging population, which in 2017 was 66.5 trillion yen (approximately US$532 billion), accounting for 12.9% of GDP. Since this method expresses the burden in monetary terms, it is expected to be a useful indicator for policy making.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Health Policy and Technology
Health Policy and Technology Medicine-Health Policy
CiteScore
9.20
自引率
3.30%
发文量
78
审稿时长
88 days
期刊介绍: Health Policy and Technology (HPT), is the official journal of the Fellowship of Postgraduate Medicine (FPM), a cross-disciplinary journal, which focuses on past, present and future health policy and the role of technology in clinical and non-clinical national and international health environments. HPT provides a further excellent way for the FPM to continue to make important national and international contributions to development of policy and practice within medicine and related disciplines. The aim of HPT is to publish relevant, timely and accessible articles and commentaries to support policy-makers, health professionals, health technology providers, patient groups and academia interested in health policy and technology. Topics covered by HPT will include: - Health technology, including drug discovery, diagnostics, medicines, devices, therapeutic delivery and eHealth systems - Cross-national comparisons on health policy using evidence-based approaches - National studies on health policy to determine the outcomes of technology-driven initiatives - Cross-border eHealth including health tourism - The digital divide in mobility, access and affordability of healthcare - Health technology assessment (HTA) methods and tools for evaluating the effectiveness of clinical and non-clinical health technologies - Health and eHealth indicators and benchmarks (measure/metrics) for understanding the adoption and diffusion of health technologies - Health and eHealth models and frameworks to support policy-makers and other stakeholders in decision-making - Stakeholder engagement with health technologies (clinical and patient/citizen buy-in) - Regulation and health economics
期刊最新文献
Identifying the risk factors of patient safety in internet hospitals: A mixed methods study Introduction of novel complex integrated care models supported by digital health interventions in European primary settings: a scoping review Trends in Medicare Charges, Reimbursements, and Utilization for Ophthalmic Versus Non-Ophthalmic Procedures A nationwide digital maturity assessment of hospitals – Results from the German DigitalRadar Applying Experienced-Based Co-Design principles to improve digital health demand management processes in a large metropolitan multi-hospital health system
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1